Frequent deletion of chromosome 1p sequences in an aggressive histologic subtype of endometrial cancer

Human Molecular Genetics

Volumn 5, Issue 7, 1996, Pages 1017-1021

  Arlt, Martin F ^a   Herzog, Thomas J ^a   Mutch, David G ^a   Gersell, Deborah J ^a   Liu, Hua ^a   Goodfellow, Paul J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CHROMOSOME 1P; CHROMOSOME DELETION; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADENOCARCINOMA, CLEAR CELL; CARCINOMA, ENDOMETRIOID; CHROMOSOME DELETION; CHROMOSOMES, HUMAN; CHROMOSOMES, HUMAN, PAIR 1; CYSTADENOCARCINOMA, PAPILLARY; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC MARKERS; HETEROZYGOTE; HUMANS; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC;

EID: 0030016121     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/5.7.1017     Document Type: Article

References (21)

1. Wingo, P.A., Tong, T. and Bolden, S. (1995) Cancer statistics, 1995. Ca:Cancer J. Clinicians 45: 8-30.
2. Wilson, T.O., Podratz, K.C., Gaffey, T.A., Malkasian, G.D., O'Brien, P.C. and Naessens, J.M. (1990) Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Am. J. Obstet.Gynecol. 162: 418-426.
3. Fanning, J., Evans, M.C., Peters, A.J., Samuel, M., Harmon, E.R. and Bates, J.S. (1989) Endometrial adenocarcinoma histologic subtypes: Clinical and pathologic profile. Gynecol. Oncol. 32: 288-291.
4. Jeffrey, J.F., Krepart, G.V., Lotocki, R.J. (1986) Papillary serous adenocarcinoma of the endometrium. Obstet. Gynecol. 67: 670-674.
5. Park, R.C., Grigsby, P.W., Hyman, B.M. and Norris, H.J. (1992) Corpus: epithelial tumors. In: Hoskins WJ, Perez CA, Young RC (eds) Principles and Practice of Gynecologic Oncology. J.B. Lippincott Company, pp. 663-693.
6. Hendrickson, M., Ross, J., Eifel, P., Martinez, A. and Kempson, R. (1982) Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am. J. Surg. Pathol. 6: 93-108.
7. Fujino, T., Risinger, J., Collins, N., Liu, F., Nishii, H., Takahashi, H., Westphal, E., Barrett, J., Sasaki, H., Kohler, M., Berchuck, A. and Boyd, J. (1994) Allelotype of endometrial carcinoma. Cancer Res. 54: 4294-4298.
8. Imamura, T., Arima, T., Kato, H., Miyamoto, S., Sasazuki, T. and Wake, N. (1992) Chromosomal deletions and K-ras gene mutations in human endometrial carcinomas. Int. J. Cancer 51: 47-52.
9. Okamoto, A., Sameshima, Y., Yamada, Y., Teshima, S., Terashima, Y., Terada, M. and Yokota, J. (1991) Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus. Cancer Res. 51: 5632-5636.
10. Peiffer, S., Herzog, T., Tribune, D., Mutch, D. and Goodfellow, P. (1995) Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial carcinomas, Cancer Res. 55: 1922-1926.
11. Jones, M., Koi, S., Fujimoto, I., Hasumi, K., Kato, K. and Nakamura, Y. (1994) Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: Frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17p. Genes Chromosomes Cancer 9: 119-123.
12. Yamada, H., Wake, N., Fujimoto, S., Barrett, J.C. and Oshimura, M. (1990) Multiple chromosomes carrying tumor suppressor activity for a uterine endometrial carcinoma cell line identified by microcell-mediated chromosome transfer. Oncogene 5: 1141-1147.
13. Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M. and Weissenbach, J. (1994) The 1993-94 Généthon human genetic linkage map. Nature Genet. 7: 246-339.
14. Weissenbach, J., Gyapay, G., Dib, C., Vignal, A., Morissette, J., Millasseau, P., Vaysseix, G. and Lathrop, M. (1992) A second-generation linkage map of the human genome. Nature 359: 794-801.
15. Arlt, M.F., Goodfellow, P.J. and Rottman, J.N. (1996) Dinucleotide repeat in the third intron of the FABP3/MDGI putative tumor suppressor gene. Disease Markers, in press.
16. Lauchlan, S.C. (1981) Tubal (serous) carcinoma of the endometrium. Arch. Pathol. Lab. Med. 105: 615-618.
17. Cairns, P., Polascik, T.J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J.L., Buckler, A., Gabrielson, E., Tockman, M., Cho, K.R., Hedrick, L., Bova, G.S., Isaacs, W., Koch, W., Schwab, D. and Sidransky, D. (1995) Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nature Genet. 11: 210-212.
18. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY. Cold Spring Harbor Laboratory Press.
19. Wright, D.K. and Manos, M.M. (1990) Sample preparation from paraffin-embedded tissues. In: Innis, M.A., Gelfand, D.H., Sninsky, J.J., White, T.J. (eds) PCR Protocols: A Guide to Methods and Applications. San Diego. Academic Press, pp. 153-158.
20. Arlt, M.F., Herzog, T.J., Mutch, T.J. and Goodfellow, P.J. (1996) Loss of heterozygosity is an infrequent event in endometrial cancer. Gynecol. Oncol. 60: 308-312.
21. Dracopoli, N.C., Bruns, G.A.P., Brodeur G.M., Landes, G.M., Matise, T.C., Seldin, M.F., Vance, J.M. and Weith, A. (1994) Report of the First International Workshop on Human Chromosome 1 Mapping 1994. Cytogenet. Cell Genet. 67: 144-165